期刊
EPIGENETICS
卷 13, 期 4, 页码 386-397出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/15592294.2018.1460034
关键词
Epigenetic regulation; colorectal cancer; DNA methylation; gene expression; prediction model; HMGA1
资金
- Matthias Lackas Foundation
- German Cancer Consortium (DKTK)
- Division of Preventive Oncology at the German Cancer Research Center (DKFZ)
- German Ministry of Education and Research (BMBF) within the e:Med consortium DeCaRe-Delineating Cardiac Regeneration
- Excellence cluster EXC 306 Inflammation at Interfaces of the German Science Foundation (DFG)
- Melanie Boerries the collaborative research center (CRC) [850]
DNA methylation is recognized as one of several epigenetic regulators of gene expression and as potential driver of carcinogenesis through gene-silencing of tumor suppressors and activation of oncogenes. However, abnormal methylation, even of promoter regions, does not necessarily alter gene expression levels, especially if the gene is already silenced, leaving the exact mechanisms of methylation unanswered. Using a large cohort of matching DNA methylation and gene expression samples of colorectal cancer (CRC; n = 77) and normal adjacent mucosa tissues (n = 108), we investigated the regulatory role of methylation on gene expression. We show that on a subset of genes enriched in common cancer pathways, methylation is significantly associated with gene regulation through gene-specific mechanisms. We built two classification models to infer gene regulation in CRC from methylation differences of tumor and normal tissues, taking into account both gene-silencing and gene-activation effects through hyper - and hypo-methylation of CpGs. The classification models result in high prediction performances in both training and independent CRC testing cohorts (0.92
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
© Peeref 2019-2024. All rights reserved.